Advisor Group Holdings Increases Stake in ResMed
June 18, 2023
🌥️Trending News
Advisor Group Holdings Inc. recently announced an increase in their investment in ResMed Inc., a global leader in medical devices and digital health solutions dedicated to improving patient outcomes. RESMED ($NYSE:RMD) Inc. offers a comprehensive portfolio of products including consumer devices, masks, humidifiers, airflow generators, and diagnostic systems, as well as cloud-based software-as-a-service solutions. The company is also a leader in the direct-to-consumer sleep health market with its award-winning MyAir and AirView consumer sleep programs.
Through its commitment to innovation and continual product development, RESMED Inc. has become a leader in the sleep and respiratory markets. Advisor Group Holdings Inc.’s increased investment in RESMED Inc. is sure to fuel its continued growth and success in the years to come.
Market Price
Advisor Group Holdings Inc. has recently increased their stake in ResMed Inc. On Friday, the stock opened at $219.8 and closed at $220.6, which is a 0.9% increase from its prior closing price of 218.7. This indicates that there is confidence in the future of ResMed Inc. and their products and services, as demonstrated by the increased stake by Advisor Group Holdings Inc. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Resmed Inc. More…
| Total Revenues | Net Income | Net Margin |
| 4.02k | 862.95 | 21.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Resmed Inc. More…
| Operations | Investing | Financing |
| 535.35 | -1.17k | 668.96 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Resmed Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 6.71k | 2.78k | 26.77 |
Key Ratios Snapshot
Some of the financial key ratios for Resmed Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.6% | 14.0% | 27.9% |
| FCF Margin | ROE | ROA |
| 10.2% | 18.3% | 10.4% |
Analysis
At GoodWhale, we have analyzed the fundamentals of RESMED INC and are pleased to share our insights. Based on our Risk Rating, we classify RESMED INC as a medium risk investment in terms of their financial and business aspects. While this risk level may be suitable for some investors, we recommend that you take a closer look at your potential investment before committing. We have also detected 1 risk warning in RESMED INC’s balance sheet. If you’re curious to learn more, please register with GoodWhale.com and access our comprehensive analysis of RESMED INC. We believe that our analysis can provide you with the insights needed to make an informed decision about this potential investment. More…
Peers
ResMed’s competitors include Natus Medical Inc, Sanara MedTech Inc, and Avita Corp.
– Natus Medical Inc ($NASDAQ:SMTI)
As of 2022, Sanara MedTech Inc has a market cap of 227.36M and a Return on Equity of -22.91%. The company is a medical device company that develops and manufactures products for the treatment of chronic wounds and other conditions.
– Sanara MedTech Inc ($TPEX:4735)
Avita Corp is a biotechnology company that develops, manufactures, and markets products based on regenerative medicine. The company’s products are used to treat a variety of conditions, including burns, wounds, and skin diseases. Avita’s products are sold in over 30 countries worldwide. The company has a market cap of 1.21B as of 2022 and a return on equity of 9.62%.
Summary
RESMED Inc is an American software and medical device company that specializes in the development of products for the diagnosis, treatment, and management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s stock has been attractive to investors recently, as evidenced by the fact that Advisor Group Holdings Inc. has recently raised its stake in the company. Analysts have generally been positive on ResMed’s recent performance, citing its strong balance sheet, strong revenue growth, and growth potential in both its core and emerging markets.
The company’s focus on diversifying its product portfolio and expanding its presence further into international markets has been cited as a key driver of future growth. With a promising outlook on the company’s future prospects, investors may want to consider looking into ResMed Inc. as a possible long-term investment.
Related Posts
Recent Posts
